Newtown, MA, United States of America

Tyler E Jacks

USPTO Granted Patents = 10 

 


Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • West Newton, MA (US) (2009)
  • Newtown, MA (US) (2017)
  • Newton, MA (US) (2018 - 2022)
  • Cambridge, MA (US) (2023)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Tyler E. Jacks

Introduction: Tyler E. Jacks, based in Newtown, Massachusetts, is a distinguished inventor known for his significant contributions to the field of genetic research. With a remarkable portfolio of nine patents, Jacks has been at the forefront of pioneering gene editing technologies and mechanisms to overcome immunosuppression in tumor environments.

Latest Patents: Among his latest innovations are two noteworthy patents. The first patent, titled "Method for Gene Editing," details compositions and methods for modifying gene sequences via systems like CRISPR-Cas9. The invention focuses on developing efficient delivery systems, including both viral and non-viral methods, to facilitate gene modification effectively. The second patent, "Methods and Compositions for Overcoming Immunosuppression," introduces novel techniques for enhancing the efficacy of effector T cells within tumor microenvironments. This innovative approach targets signaling pathways involving ST2 and IL-33, aiming to inhibit tumor growth and enhance the infiltration of cytotoxic T cells.

Career Highlights: Tyler E. Jacks has achieved notable career milestones primarily through his affiliations with prestigious institutions. He has worked with the Massachusetts Institute of Technology (MIT) and the Whitehead Institute for Biomedical Research, where he has made significant strides in cancer research and gene therapy. His work has led to advancements that have the potential to revolutionize treatment options for patients battling various forms of cancer.

Collaborations: Throughout his career, Jacks has collaborated with esteemed colleagues, including Daniel Griffith Anderson and Hao Yin. These partnerships have enabled a dynamic exchange of ideas and innovations, propelling forward the boundaries of biomedical research and technology.

Conclusion: In summary, Tyler E. Jacks exemplifies the spirit of innovation in the realm of genetic research. His contributions, underscored by his patents and collaborations, inspire a new wave of breakthroughs in gene editing and cancer treatment. As the field of biomedical engineering continues to evolve, Jacks' work will undoubtedly remain influential in shaping the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…